Stocks
Immunome (IMNM) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.12 | -0.19 | -2.71 | -2.71 | -5.81 | -6.38 | ||
| Changes by years, y/y, % | +19% | -95% | +1 351% | +0% | +114% | +11.0% | |||
Immunome. EV/EBITDA
Immunome. EV/EBITDA, changes, %
Immunome (IMNM) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | -3.00 | -1.27 | -2.90 | -3.78 | -5.88 | -6.38 | |
| Changes by years, y/y, % | -14% | -203% | -54% | -35% | +96% | |||
| Changes by quarters, q/q, % | -49% | -58% | +129% | +30% | +56% | |||
